Burning Rock Biotech
38 hedge funds and large institutions have $396M invested in Burning Rock Biotech in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 21 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
0.02% more ownership
Funds ownership: 1.87% → 1.89% (+0.02%)
7% less capital invested
Capital invested by funds: $426M → $396M (-$29.9M)
19% less funds holding
Funds holding: 47 → 38 (-9)
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$11.9M |
| 2 |
HSBC Holdings
London,
United Kingdom
|
+$11.7M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$6.96M |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$5.15M |
| 5 |
CC
Casdin Capital
New York
|
+$4.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$10.2M |
| 2 |
JP Morgan Chase
New York
|
-$8.53M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.75M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$5.4M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$3.62M |
BNR Hedge Fund Activity: Q3 2020 in Review
38 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q3 2020, worth a combined $396M — down 7% from $426M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of BNR and 12 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 10 added.
The largest buyer was Ameriprise, adding an estimated $11.9M. The largest seller was Matthews International Capital Management, cutting an estimated $10.2M.
- 38 institutional investors held Burning Rock Biotech (BNR) as of Q3 2020, down from 47 in Q2 2020.
- Funds reported $396M of Burning Rock Biotech stock for Q3 2020, down 7% quarter-over-quarter.
- 12 funds opened new Burning Rock Biotech positions in Q3 2020 and 21 closed out, a net change of -9 holders.
- The largest Burning Rock Biotech buyer in Q3 2020 was Ameriprise, an estimated $11.9M added.
- The largest Burning Rock Biotech seller in Q3 2020 was Matthews International Capital Management, an estimated $10.2M sold.
Based on aggregated 13F filings for Q3 2020.